MedPath

Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies

Not Applicable
Withdrawn
Conditions
Hemicraniectomies
Interventions
Biological: ViaShield
Registration Number
NCT03371316
Lead Sponsor
Globus Medical Inc
Brief Summary

The goal of this study is to demonstrate that ViaShield™ amnion patch is effective in preventing fibroblast activity and hence soft tissue adhesions after a hemicraniectomy.

Detailed Description

A hemicraniectomy is a surgical procedure in which part of the skull is temporarily removed to relieve pressure on the underlying brain. Hemicraniectomies are typically performed on patients experiencing severe brain injury, usually due to stroke or trauma. In these cases, the brain injury and swelling is so severe that it can lead to brain compression and brain death. As a result, a surgeon will remove the bone flap to help with brain swelling and increased intracranial pressure. After the patient heals, a cranioplasty will be performed to restore the bone flap to its original location.

When the central nervous system is deprived of its normal covering, as is the case with hemicraniectomies, the exposed area becomes the site of cellular reaction from surrounding tissue1 and soft tissue adhesions frequently develop between the skin flap and the dura mater or exposed brain, which may lead to less than optimal clinical outcome.

ViaShield™ is an amnion patch produced from human amniotic membrane. Because of its inherent anti-adhesive properties, amnion serves as an ideal barrier against scarring and soft tissue adhesions to the neural elements, anterior vessels and hardware.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

18 years of age minimum Informed consent signed by patient or next of kin

Exclusion Criteria

Immunosuppressive disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hemicraniectomy Surgery with ViashieldViaShieldAll patients requiring a hemicraniectomy surgery will receive the anti-adhesion barrier of amnion patch.
Primary Outcome Measures
NameTimeMethod
Adhesion4-8 months

Adhesion tenacity scores post hemicraniectomies 0 No adhesions

1. Thin membranous adhesions, no vessel attachment

2. Mild adhesions, blunt dissection required

3. Moderate adhesions, some sharp dissection required

4. Tenacious adhesions, sharp instrument dissection required, vessels attached The lower the score the better the outcome for the patient

Secondary Outcome Measures
NameTimeMethod
InfectionsFrom time of surgery to 8 months post-operative

Wound Infections in or around hemicraniectomy site

hydrocephalusFrom time of surgery to 8 months post-operative

Accumulation of fluid around the brain

© Copyright 2025. All Rights Reserved by MedPath